Cetuximab, a humanized monoclonal antibody against epidermal growth factor receptor (EGFR) [32], has been linked to IR700 resulting in the generation of a conjugate that showed high selectivity and efficacy against various cancer types both in vitro and in vivo [9]. Here, EGFR is linked to cancer.